How cannabis compounds protect blood vessels during severe infection

This systematic review examines how the body's natural endocannabinoid system (ECS) affects blood vessel function during sepsis, a life-threatening condition involving severe infection and organ failure. Researchers analyzed 11 experimental studies that tested how activating or blocking different cannabinoid receptors influences the inflammatory damage that occurs in tiny blood vessels during sepsis. The study reveals that the endocannabinoid system plays a critical protective role by preventing excessive inflammation and maintaining the integrity of blood vessel walls, which are key factors in whether sepsis patients survive organ failure.

The most significant finding centers on cannabinoid receptor 2 (CB2), which consistently showed protective effects across multiple experimental models. When CB2 is activated, it reduces the adhesion molecules that cause immune cells to stick to blood vessel walls, effectively limiting damaging inflammatory cell recruitment to affected tissues. Additionally, the research identified that endocannabinoid-endovanilloid signaling helps stabilize the tight junctions between endothelial cells, preventing the dangerous fluid leakage that characterizes septic shock. The cannabinoid receptor 1 (CB1) showed more variable effects on blood vessel tone, suggesting context-dependent mechanisms that warrant further investigation.

These findings establish a compelling framework for understanding how naturally-occurring cannabinoid signaling protects the microcirculation during sepsis, suggesting that targeted activation of ECS pathways—particularly CB2—could represent a novel therapeutic strategy for preventing organ failure in sepsis patients. However, the authors emphasize that more standardized, clinically-relevant models are needed before these laboratory discoveries can translate into effective treatments. This research underscores the endocannabinoid system's fundamental role in vascular inflammation and resilience.